Day One to Participate in the Piper Sandler 36th Annual Healthcare Conference
Day One Biopharmaceuticals (Nasdaq: DAWN) has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The company's management will engage in a fireside chat on Tuesday, December 3 at 3:00 p.m. EST.
Interested parties can access a live webcast of the discussion through the Events & Presentations section of Day One's Investors & Media page. The webcast recording will remain available for 30 days after the live event.
Day One Biopharmaceuticals (Nasdaq: DAWN) ha annunciato la sua partecipazione alla 36a Conferenza Annuale sulla Salute di Piper Sandler. Il management dell'azienda parteciperà a una chiacchierata informale martedì 3 dicembre alle 15:00 EST.
Le parti interessate possono accedere a un webcast dal vivo della discussione attraverso la sezione Eventi & Presentazioni della pagina Investor & Media di Day One. La registrazione del webcast rimarrà disponibile per 30 giorni dopo l'evento dal vivo.
Day One Biopharmaceuticals (Nasdaq: DAWN) ha anunciado su participación en la 36ª Conferencia Anual de Salud de Piper Sandler. La dirección de la compañía participará en un chat informal el martes 3 de diciembre a las 3:00 p.m. EST.
Las partes interesadas pueden acceder a un webcast en vivo de la discusión a través de la sección Eventos y Presentaciones en la página de Inversores y Medios de Day One. La grabación del webcast estará disponible durante 30 días después del evento en vivo.
Day One Biopharmaceuticals (Nasdaq: DAWN)는 Piper Sandler 제36회 연례 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 12월 3일 화요일 오후 3시(EST)에 화상 대화에 참여할 예정입니다.
관심 있는 분들은 Day One의 투자자 및 미디어 페이지의 이벤트 및 발표 섹션을 통해 생중계 웹캐스트에 접속할 수 있습니다. 생중계 이벤트 후 30일 동안 웹캐스트 녹화본이 제공됩니다.
Day One Biopharmaceuticals (Nasdaq: DAWN) a annoncé sa participation à la 36ème Conférence Annuelle sur la Santé de Piper Sandler. La direction de l'entreprise participera à une discussion informelle le mardi 3 décembre à 15h00 EST.
Les parties intéressées peuvent accéder à un webinaire en direct de la discussion via la section Événements & Présentations de la page Investisseurs & Médias de Day One. L'enregistrement du webinaire sera disponible pendant 30 jours après l'événement en direct.
Day One Biopharmaceuticals (Nasdaq: DAWN) hat seine Teilnahme an der 36. jährlichen Gesundheitskonferenz von Piper Sandler bekannt gegeben. Das Management des Unternehmens wird am Dienstag, den 3. Dezember um 15:00 Uhr EST an einem informellen Gespräch teilnehmen.
Interessierte Parteien können über den Bereich Veranstaltungen & Präsentationen auf der Investoren- und Medienseite von Day One auf ein live-Webcast der Diskussion zugreifen. Die Aufzeichnung des Webcasts wird 30 Tage nach der Live-Veranstaltung verfügbar sein.
- None.
- None.
BRISBANE, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that management will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3 at 3:00 p.m. EST.
A live webcast of the discussion will be available by visiting the Events & Presentations section of the Day One Investors & Media page. An archived replay of the webcast will be available for 30 days following the live event.
About Day One Biopharmaceuticals
Day One Biopharmaceuticals believes when it comes to pediatric cancer, we can do better. The Company was founded to address a critical unmet need: the dire lack of therapeutic development in pediatric cancer. Inspired by “The Day One Talk” that physicians have with patients and their families about an initial cancer diagnosis and treatment plan, Day One aims to re-envision cancer drug development and redefine what’s possible for all people living with cancer—regardless of age—starting from Day One.
Day One partners with leading clinical oncologists, families, and scientists to identify, acquire, and develop important targeted cancer treatments. The Company’s pipeline includes tovorafenib (OJEMDA™), DAY301 and a VRK1 inhibitor program.
Day One is based in Brisbane, California. For more information, please visit www.dayonebio.com or find the Company on LinkedIn or X.
Day One uses its Investor Relations website (ir.dayonebio.com), its X handle (x.com/DayOneBio), and LinkedIn Home Page (linkedin.com/company/dayonebio) as a means of disseminating or providing notification of, among other things, news or announcements regarding its business or financial performance, investor events, press releases, and earnings releases, and as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD.
DAY ONE MEDIA
Laura Cooper, Head of Communications
media@dayonebio.com
DAY ONE INVESTORS
LifeSci Advisors, PJ Kelleher
pkelleher@lifesciadvisors.com
FAQ
When is Day One Biopharmaceuticals (DAWN) presenting at the Piper Sandler Healthcare Conference?
How can I watch Day One Biopharmaceuticals' (DAWN) presentation at the Piper Sandler Conference?
How long will Day One Biopharmaceuticals' (DAWN) Piper Sandler Conference webcast be available?
What type of presentation will Day One Biopharmaceuticals (DAWN) give at the Piper Sandler Conference?
